J&J

Within J&J's consumer health business, its skin care brands Neutrogena and Aveena have performed strongly worldwide [Getty Images]

‘Our strategy is working’: J&J Q3 net profit soars 21.6%

By Kacey Culliney

Personal care major Johnson & Johnson (J&J) has reported a rise in third quarter (Q3) sales and a surge in net profit, bolstered by strong growth in pharma and med tech but also solid results across its global consumer health business.